Skip to main content
      RT @EJoerns: Excited to share our recent work "IPAF: What the Rheumatologist Needs to Know."
      @jeffsparks @UnaMakris @Dr

      Elena Joerns EJoerns

      2 years 5 months ago
      Excited to share our recent work "IPAF: What the Rheumatologist Needs to Know." @jeffsparks @UnaMakris @DrDavidKarp @UTSW_LungLadies @UTSWRheum https://t.co/O0BsrRyHx8 https://t.co/R3lQMGFgUb
      RT @kunalchandwar: 🔥Hot off the press🔥
      🆕Our Comments on various GC protocols in @IJRheum
      The changing paradigm

      Kunal Chandwar kunalchandwar

      2 years 5 months ago
      🔥Hot off the press🔥 🆕Our Comments on various GC protocols in @IJRheum The changing paradigm of glucocorticoid therapy in antineutrophil cytoplasmic antibody-associated vasculitis https://t.co/4BjfkvPVAY https://t.co/gMXg7qQJWY
      RT @drpnash: do we need another IL17a inhibitor? https://t.co/yf8cFNruzU

      Peter Nash drpnash

      2 years 5 months ago
      do we need another IL17a inhibitor? https://t.co/yf8cFNruzU
      RT @uptoTate: "Implementation (of guidelines) is key but remains the weakest part of the process" Dr. @DanielAletaha #EU

      Dr. Rachel Tate uptoTate

      2 years 5 months ago
      "Implementation (of guidelines) is key but remains the weakest part of the process" Dr. @DanielAletaha #EULAR2022 @RheumNow https://t.co/9ULIAA7dvg
      RT @RheumTweeter: Easy clinical tool for predicting lymphoma development at the time of #Sjogrens syndrome #EULAR2022 ht

      Christian Ammitzbøll RheumTweeter

      2 years 5 months ago
      Easy clinical tool for predicting lymphoma development at the time of #Sjogrens syndrome #EULAR2022 https://t.co/tQ6B0iVRnb
      RT @RichardPAConway: Dr Buch. ORAL Surveillance. MACE, VTE, Malignancy all more common in those with high (>20%) base

      Richard Conway RichardPAConway

      2 years 5 months ago
      Dr Buch. ORAL Surveillance. MACE, VTE, Malignancy all more common in those with high (>20%) baseline CV risk or history CAD. HRs 1-2 for most but for VTE and high baseline CV risk, HR 6-11! @RheumNow #EULAR2022 POS0237 https://t.co/9DI4KotyOp
      RT @ARD_BMJ: Dr Elena Nikiphorou explaining how the Western diet can bring on and worsen inflammation joint disease symp

      ARD & RMD Open ARD_BMJ

      2 years 5 months ago
      Dr Elena Nikiphorou explaining how the Western diet can bring on and worsen inflammation joint disease symptoms. We should look to include more Omega 3 than Omega 6 in our diets #EULAR2022 PB https://t.co/nIKOSDPURU
      RT @AshimaMakol: A very comprehensive overview of progress in the understanding of #IIM pathogenetic mechanisms outlinin

      Ashima Makol MD AshimaMakol

      2 years 5 months ago
      A very comprehensive overview of progress in the understanding of #IIM pathogenetic mechanisms outlining the role of 👉 Type 1 INF pathway 👉 Vasculopathy 👉 NETs 👉 Mitochondrial Dysfunction #EULAR2022 Dr. Lisa Rider https://t.co/BXbXlYTHYM
      RT @RichardPAConway: van Dijk et al. MTP squeeze positivity is caused by both MTP synovitis (OR 3.2 (1.4–7.2) and inte

      Richard Conway RichardPAConway

      2 years 5 months ago
      van Dijk et al. MTP squeeze positivity is caused by both MTP synovitis (OR 3.2 (1.4–7.2) and intermetatarsal bursitis (OR 3.9 (1.7–8.8)). If + MTP squeeze - 10% synovitis, 15% IMB and 13% both @RheumNow #EULAR2022 OP0290 https://t.co/eVSU4i8gBK
      RT @drdavidliew: Robert Landewe isn't lying down.

      "I am chatting to my artificial intelligence doctor in the United Sta

      David Liew drdavidliew

      2 years 5 months ago
      Robert Landewe isn't lying down. "I am chatting to my artificial intelligence doctor in the United States. I am asking him why I had a headache in the last talk" He worries telehealth reverts to box checking, & we're not ready to drop thinking from medicine #EULAR2022 @RheumNow https://t.co/ApBS4T4Wpc
      RT @ARD_BMJ: CAR-T cell treatment of refractory systemic #lupus
      Biological results
      #SLE
      #EULAR2022

      >CR https://t.co/

      ARD & RMD Open ARD_BMJ

      2 years 5 months ago
      CAR-T cell treatment of refractory systemic #lupus Biological results #SLE #EULAR2022 >CR https://t.co/JK4lsWcn2c
      RT @AurelieRheumo: Remission in PsA

      ❗️According to DAS28-CRP
      *22% never achieve a state of remission
      *< than ha

      Aurelie Najm AurelieRheumo

      2 years 5 months ago
      Remission in PsA ❗️According to DAS28-CRP *22% never achieve a state of remission *< than half achieved at least stage of SR ❗️According to DAPSA28 *73% never achieve a state of remission Are we that bad? Or do we need different measures? Or both? @RheumNow OP0262 #EULAR2022 https://t.co/6aeNW17VWg
      RT @AurelieRheumo: 📈 Machine learning driven phenotyping in PsA

      4 clusters of pts treated w/ Guselkumab identified

      Aurelie Najm AurelieRheumo

      2 years 5 months ago
      📈 Machine learning driven phenotyping in PsA 4 clusters of pts treated w/ Guselkumab identified 📊 1 cluster w/ higher BL disease burden associated w/ worst response As fancy as it gets, not sure how to implement these in practice 🧐 @RheumNow #EULAR2022 OP0259 https://t.co/75X4ZqeEQJ
      RT @Janetbirdope: @RichardPAConway @CatherineL_Hill @rheum_cat @RheumNow @KDAO2011 @uptoTate @AurelieRheumo Hello. @Rheu

      Janet Pope Janetbirdope

      2 years 5 months ago
      @RichardPAConway @CatherineL_Hill @rheum_cat @RheumNow @KDAO2011 @uptoTate @AurelieRheumo Hello. @RheumNow reports @eular_org #EULAR2022 and teaches many. I learn as a tweeter. Way to go for all people tweeter this meeting. https://t.co/W3DuoVdfby
      RT @Yuz6Yusof: When Tweeps meet IRL #EULAR2022 #queensjubilee2022 @YelizPrior @DrMiniDey @chriswincup https://t.co/cnTFw

      Md Yuzaiful Md Yusof Yuz6Yusof

      2 years 5 months ago
      When Tweeps meet IRL #EULAR2022 #queensjubilee2022 @YelizPrior @DrMiniDey @chriswincup https://t.co/cnTFw2jjVd